AU2002360243A1 - Agents that activate or inhibit toll-like receptor 9 - Google Patents

Agents that activate or inhibit toll-like receptor 9

Info

Publication number: AU2002360243A1
Authority: AU; Australia
Prior art keywords: receptor; activate; agents; inhibit toll; toll
Prior art date: 2001-07-26
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2002360243A

Inventor

Ling-Ling An

Michael S. C. Fung

Herren Wu

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Tanox Inc

Original Assignee

Tanox Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-07-26

Filing date

2002-07-25

Publication date

2003-05-06

2002-07-25 Application filed by Tanox Inc filed Critical Tanox Inc

2003-05-06 Publication of AU2002360243A1 publication Critical patent/AU2002360243A1/en

Status Abandoned legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55516—Proteins; Peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Immunology (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Genetics & Genomics (AREA)
Medicinal Chemistry (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Life Sciences & Earth Sciences (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AU2002360243A 2001-07-26 2002-07-25 Agents that activate or inhibit toll-like receptor 9 Abandoned AU2002360243A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US30806801P	2001-07-26	2001-07-26
US60/308,068		2001-07-26
PCT/US2002/023645 WO2003035695A2 (en)	2001-07-26	2002-07-25	Agents that activate or inhibit toll-like receptor 9

Publications (1)

Publication Number	Publication Date
AU2002360243A1 true AU2002360243A1 (en)	2003-05-06

Family

ID=23192407

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2002360243A Abandoned AU2002360243A1 (en)	2001-07-26	2002-07-25	Agents that activate or inhibit toll-like receptor 9

Country Status (4)

Country	Link
EP (1)	EP1412390A2 (en)
CN (1)	CN1642982A (en)
AU (1)	AU2002360243A1 (en)
WO (1)	WO2003035695A2 (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2001291096A1 (en)	2000-09-15	2002-03-26	Coley Pharmaceutical Gmbh	Process for high throughput screening of CpG-based immuno-agonist/antagonist
IL160561A0 (en)	2001-09-07	2004-07-25	Univ Boston	Method and composition for treating immune complex associated disorders
KR20060016817A (en) *	2003-06-20	2006-02-22	콜리 파마슈티칼 게엠베하	Small molecule toll-like receptor (TLL) antagonists
US20050208470A1 (en) *	2003-12-16	2005-09-22	University Of Massachusetts	Toll-like receptor assays
EP1768699A1 (en) *	2004-07-20	2007-04-04	Shering Corporation	Induction of apoptosis in toll-like receptor expressing tumor cells
EP1829895A1 (en) *	2006-03-03	2007-09-05	f-star Biotechnologische Forschungs- und Entwicklungsges.m.b.H.	Bispecific molecule binding TLR9 and CD32 and comprising a T cell epitope for treatment of allergies
US9636415B2 (en)	2006-03-03	2017-05-02	S-Target Therapeutics Gmbh	Bispecific molecule binding TLR9 and CD32 and comprising a T cell epitope for treatment of allergies
CN101240271B (en) *	2006-08-28	2012-08-29	长春华普生物技术有限公司	Toll-like receptor modulating oligonucleotides and uses thereof
CN101134046B (en) *	2006-09-01	2011-10-05	中国医学科学院药物研究所	Application of TLR4 and TLR9 agonist compound in inhibiting tumor metastasis
WO2010030790A2 (en) *	2008-09-10	2010-03-18	The Texas A&M University System	Methods and compositions for stimulation of mammalian innate immune resistance to pathogens
CN105126072B (en)	2009-03-25	2020-05-15	德克萨斯大学系统董事会	Compositions for stimulating innate immune resistance to pathogens in mammals
US8450285B2 (en)	2009-06-05	2013-05-28	13Therapeutics, Inc.	Immunoregulatory peptides and methods of use
EP2496944A2 (en) *	2009-11-05	2012-09-12	Novartis AG	Biomarkers predictive of progression of fibrosis
CN101712957B (en) *	2009-11-25	2011-11-23	中国人民解放军第三军医大学第一附属医院	Toll-like receptor 9 blocker and application
FR2975600B1 (en)	2011-05-24	2013-07-05	Assist Publ Hopitaux De Paris	AGENTS FOR THE TREATMENT OF TUMORS
AR095882A1 (en)	2013-04-22	2015-11-18	Hoffmann La Roche	ANTIBODY COMBINATION THERAPY AGAINST HUMAN CSF-1R WITH A TLR9 AGONIST
US11009511B2 (en)	2014-05-16	2021-05-18	Ablynx N.V.	Methods for detecting and/or measuring anti-drug antibodies, in particular treatment-emergent anti-drug antibodies
EP3143042B1 (en)	2014-05-16	2020-06-10	Ablynx N.V.	Immunoglobulin variable domains
WO2016044839A2 (en)	2014-09-19	2016-03-24	The Board Of Regents Of The University Of Texas System	Compositions and methods for treating viral infections through stimulated innate immunity in combination with antiviral compounds
WO2019066571A2 (en)	2017-09-28	2019-04-04	연세대학교 산학협력단	Method for producing myeloid-derived suppressor cells, myeloid-derived suppressor cells produced thereby, and uses thereof
WO2021207653A1 (en) *	2020-04-10	2021-10-14	Idera Pharmaceuticals, Inc.	Use of a tlr9 agonist in methods for treating covid-19
WO2022242652A1 (en) *	2021-05-18	2022-11-24	Hung, Mien-Chie	Vaccine, use thereof and cancer vaccine cocktail

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0001704D0 (en) *	2000-01-25	2000-03-15	Glaxo Group Ltd	Protein
AU8181201A (en) *	2000-06-08	2001-12-17	Cistem Biotechnologies Gmbh	Immunostimulatory oligodeoxynucleotides
JP2002034565A (en) *	2000-07-19	2002-02-05	Japan Science & Technology Corp	Receptor protein that specifically recognizes bacterial DNA

2002
- 2002-07-25 EP EP02795487A patent/EP1412390A2/en not_active Withdrawn
- 2002-07-25 AU AU2002360243A patent/AU2002360243A1/en not_active Abandoned
- 2002-07-25 WO PCT/US2002/023645 patent/WO2003035695A2/en not_active Ceased
- 2002-07-25 CN CN 02818821 patent/CN1642982A/en active Pending

Also Published As

Publication number	Publication date
EP1412390A2 (en)	2004-04-28
WO2003035695A3 (en)	2003-11-13
WO2003035695A2 (en)	2003-05-01
CN1642982A (en)	2005-07-20

Publication	Publication Date	Title
AU2002360243A1 (en)	2003-05-06	Agents that activate or inhibit toll-like receptor 9
AU2001228665A1 (en)	2001-08-07	Toll-like receptor
AU2002248740A1 (en)	2002-10-15	Synthetic transaction monitor
AU2001288040A1 (en)	2002-03-26	Homeostasis-maintaining agents
AU2002214284A1 (en)	2002-05-27	Anti-helicobacterial agents
AU2002224595A1 (en)	2002-02-13	Antitumor agents
AU2002366214A1 (en)	2003-06-10	Distributing device
EP1273811A3 (en)	2003-09-10	Fastening means
AU2002362138A1 (en)	2003-06-23	Toll-like receptor 4 mutations
IL160539A0 (en)	2004-07-25	Anti-influenzal agents
AU2001223882A1 (en)	2001-07-24	Receptor
EP1302588A3 (en)	2004-09-22	Water-impermeable carpet
AUPR253901A0 (en)	2001-02-08	Emulsifier
GB2374641B (en)	2004-09-01	Screw-threaded fastening
AU2003213801A1 (en)	2003-09-29	Toll-like receptor 11
AU2002361351A1 (en)	2003-06-10	24 volt-battery device
AU2001277537A1 (en)	2002-03-04	Agents
AU2002226736A1 (en)	2002-08-12	Anticancer agents
AU2002313219A1 (en)	2003-01-02	Anticancer agents
AUPR493301A0 (en)	2001-06-07	Foaming agents
AU2002313260A1 (en)	2003-01-08	Antitumor agents
AU2002309041A1 (en)	2002-11-25	Antitumor agents
HK1057564A (en)	2004-04-08	Flame-proofing agents
AU2002218308A1 (en)	2002-07-30	Flame-proofing agents
AU2002248005A1 (en)	2002-10-28	Visual function improving agents

Legal Events

Date	Code	Title	Description
2004-04-08	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase